Riskpilot← Back to searchSign inGet full accessCibex Medica AB
ABActiveOrg 5569006629Ekollongatan 16Activities of holding companies · NACE 6421Est. 20120 employees
Revenue 2025
SEK 0
EBITDA margin
—
-112% vs 2024
Equity ratio
99.9%
Financial strength
Net profit 2025
SEK 4M
+46041% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -1K | -112% |
| Net profit | SEK 4M | +46041% |
| Total assets | SEK 4,1M | +5807% |
| Equity | SEK 4,1M | +6129% |
| Employees | 0 | — |
Legal name
Cibex Medica AB
Org number
5569006629
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
15 augusti 2012
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att äga och förvalta aktier i dotterbolag och värdepapper därmed förenlig verksamhet.
Address
Ekollongatan 16
Email
reinesjoman@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 67 | 31 | 0 | 17 | 0 |
| Staff expenses | — | −13 | −0 | — | — |
| EBITDA | 62 | −9 | −23 | 9 | −1 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 62 | −9 | −23 | 9 | −1 |
| Net financials | — | — | 0 | 0 | 4 000 |
| Profit before tax | 62 | −9 | −23 | 9 | 3 999 |
| Tax | −0 | — | — | — | — |
| Net profit | 62 | −9 | −23 | 9 | 3 999 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 108 | 87 | 61 | 69 | 4 068 |
| Equity | 88 | 80 | 57 | 65 | 4 064 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 20 | 8 | 4 | 4 | 4 |
| Total debt | 20 | 8 | 4 | 4 | 4 |
EBITDA margin
-100100.0%
This company
15.8%
Market median
-633644% vs market
20212025
Equity ratio
99.9%
This company
38.2%
Market median
+162% vs market
20212025
Return on equity
98.4%
This company
18.4%
Market median
+435% vs market
20212025
Net profit margin
399901800.0%
This company
8.1%
Market median
+4937059159% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2024 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Cibex Medica AB 
Linköping Käkkirurgiska centrum ABBoard members of Cibex Medica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Reine Erik Sjöman | Board of Directors | 0 companies |
| Katrin Ingeborg Sjöman | Deputy Board Member | 0 companies |
| Johnny Elon Alrich Sjöman | Deputy Board Member | 0 companies |